Rein Therapeutics, Inc. Shareholders' Equity
Rein Therapeutics, Inc. (RNTX) had Shareholders' Equity of $55.20 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $55.20M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $11.59M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $16.92M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $46.19M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $55.20M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $11.59M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $16.92M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $46.19M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $48.01M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $49.88M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $54.39M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $95.23M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $101.02M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $91.33M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $98.30M 10-K · filed 2026-03-26 | $6.89M 10-K · filed 2024-04-15 |
| 2023-09-30 | $11.20M 10-Q · filed 2023-10-13 | |
| 2023-06-30 | $12.79M 10-Q · filed 2023-10-13 | |
| 2023-03-31 | $14.27M 10-Q · filed 2023-10-13 | |
| 2022-12-31 | $18.62M 10-K · filed 2025-04-07 | |
| 2022-09-30 | $22.70M 10-Q · filed 2023-10-13 | |
| 2022-06-30 | $28.62M 10-Q · filed 2023-10-13 | |
| 2022-03-31 | $36.11M 10-Q · filed 2023-10-13 | |
| 2021-12-31 | $43.90M 10-Q · filed 2023-10-13 | |
| 2021-09-30 | $50.11M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $56.13M 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $61.42M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $12.16M 10-K · filed 2023-03-20 | |
| 2020-09-30 | $12.46M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $16.65M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $9.77M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $16.05M 10-K · filed 2022-03-28 | |
| 2019-09-30 | $22.82M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $29.98M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $12.85M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $19.60M 10-K · filed 2021-03-24 | |
| 2018-09-30 | $26.03M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $32.87M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $40.98M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $47.80M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $54.01M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$120.78M 10-Q · filed 2017-08-10 | |
| 2016-12-31 | -$111.81M 10-K · filed 2019-03-29 | |
| 2015-12-31 | -$94.32M 10-K · filed 2018-04-02 | |
| 2014-12-31 | -$82.04M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |